Glycorex Transplantation
0,85 SEK +6,25%Vær den første som følger denne virksomhed
Glycorex Transplantation is a biotechnology company. The company conducts research, development, and marketing within the field of organ transplantation. The main product of the company, Glycosorb-ABO, enables transplants irrespective of the blood type of the donors and the recipients. Transplants with the help of the company's product have been carried out worldwide. Glycorex Transplantation was founded in 1996 and is based in Lund.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NGM Main Regulated
GTAB B
Daglig lav / høj pris
0,76 / 0,85
SEK
Markedsværdi
62,78 mio. SEK
Aktieomsætning
72,16 t SEK
Volumen
92 t
Finanskalender
Delårsrapport
29.08.2024
Delårsrapport
28.11.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Avanza Pension | 10,9 % | 7,8 % |
Wendt Investment AB | 7,1 % | 5,1 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Glycorex Transplantation: First publication from South Africa and first stem cell transplantation performed in Mexico
Glycorex Transplantation (GTAB B): Signs agreement with distributor in Romania
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools